Business Segments · Receivables, net
North American Pharmaceutical — Receivables, net
McKesson North American Pharmaceutical — Receivables, net increased by 41.5% to $443.00M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026
Rolls up toAccounts Receivable
How to read this metric
An increase relative to revenue may signal deteriorating customer credit quality or extended payment terms, while a decrease may indicate improved collections or tighter credit policies.
Detailed definition
This metric represents the net amount of trade receivables owed to the North American Pharmaceutical segment by its cust...
Peer comparison
Comparable to 'Accounts Receivable, net' found in the segment reporting or balance sheet footnotes of major pharmaceutical wholesalers and healthcare distributors.
Metric ID:
mck_segment_north_american_pharmaceutical_receivables_netHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $313.00M | $443.00M |
| QoQ Change | — | +41.5% |
| YoY Change | — | +41.5% |
Range$313.00M – $443.00M
Avg YoY Growth+41.5%
Median YoY Growth+41.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's north american pharmaceutical — receivables, net?
- McKesson (MCK) reported north american pharmaceutical — receivables, net of $443.00M in Q1 2026.
- What does north american pharmaceutical — receivables, net mean?
- The net amount of money owed to the pharmaceutical distribution segment by its customers for products delivered, adjusted for potential non-payment.